Drug excretion into breast milk - Overview

被引:115
作者
Ito, S [1 ]
Lee, A [1 ]
机构
[1] Hosp Sick Children, Div Clin Pharmacol & Toxicol, Dept Pediat, Toronto, ON M5G 1X8, Canada
关键词
adherence; breastfeeding; drug effect; drug therapy; drug transfer; human milk; milk production; neonate;
D O I
10.1016/S0169-409X(03)00034-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Breastfeeding is the optimal form of infant feeding for the first months of an infant's life, and the majority of healthy women initiate breastfeeding after the birth of their infant. However, women on medication may default to formula feeding or not taking their drug therapy for fear of exposing their infant to the medication through the breast milk. Although the majority of medications are considered to be compatible with breastfeeding, cases of significant infant toxicity exist, suggesting a case by case risk assessment to be made before the mother initiates breastfeeding or drug therapy. Unfortunately, current clinical risk assessment is often compromised by the paucity of data, as studies in breastfeeding women and their infants are ethically difficult to conduct. Circumventing the ethical constraints, approaches have been proposed to estimate drug excretion into milk from physicochemical characteristics of the drug, which diffuses through the mammary gland epithelia. However, as our understanding on drug transfer mechanisms increases, it has become abundantly clear that carrier-mediated processes are involved with excretion of a number of drugs into milk. This article provides an overview of the benefits of breastfeeding, the effect of medication use during breastfeeding on maternal decisions and infant health, and factors determining infant exposure to medication through the breast milk. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:617 / 627
页数:11
相关论文
共 98 条
[21]   MATERNAL WEIGHT-LOSS PATTERNS DURING PROLONGED LACTATION [J].
DEWEY, KG ;
HEINIG, MJ ;
NOMMSEN, LA .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1993, 58 (02) :162-166
[22]   DIFFERENCES IN MORBIDITY BETWEEN BREAST-FED AND FORMULA-FED INFANTS [J].
DEWEY, KG ;
HEINIG, J ;
NOMMSENRIVERS, LA .
JOURNAL OF PEDIATRICS, 1995, 126 (05) :696-702
[23]  
DRANE D, 1997, BREASTFEEDING REV, V5, P7
[24]   Influences on breastfeeding rates in low income communities in Ontario [J].
Evers, S ;
Doran, L ;
Schellenberg, K .
CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 1998, 89 (03) :203-207
[25]  
Fergusson DM, 1999, PAEDIATR PERINAT EP, V13, P144
[26]   FACTORS AFFECTING THE MILK-TO-PLASMA DRUG CONCENTRATION RATIO IN LACTATING WOMEN - PHYSICAL INTERACTIONS WITH PROTEIN AND FAT [J].
FLEISHAKER, JC ;
DESAI, N ;
MCNAMARA, PJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (03) :189-193
[27]  
FOMINAL PI, 1965, J PEDIAT, V66, P1068
[28]   Adverse effects in a newborn infant breast-fed by a mother treated with doxepin [J].
Frey, OR ;
Scheidt, P ;
von Brenndorff, AI .
ANNALS OF PHARMACOTHERAPY, 1999, 33 (06) :690-693
[29]  
Gartner LM, 1997, PEDIATRICS, V100, P1035, DOI 10.1542/peds.100.6.1035
[30]   Sodium dependence of nitrofurantoin active transport across mammary epithelia and effects of dipyridamole, nucleosides, and nucleobases [J].
Gerk, PM ;
Hanson, L ;
Neville, MC ;
McNamara, PJ .
PHARMACEUTICAL RESEARCH, 2002, 19 (03) :299-305